Bicara Therapeutics (NasdaqGM:BCAX) Update / briefing Transcript

Bicara Therapeutics (NasdaqGM:BCAX) Update / briefing February 20, 2026 08:30 AM ET Company ParticipantsBill Schelman - EVP of Clinical DevelopmentClaire Mazumdar - CEOJenna Cohen - Chief Corporate Affairs OfficerReni Benjamin - Managing DirectorStephen Willey - Managing DirectorConference Call ParticipantsEric Schmidt - Biotechnology AnalystJeet Mukherjee - VP and Biotechnology AnalystJudah Frommer - Executive Director and Senior Equity Research AnalystKelsey Goodwin - Director and Senior Research AnalystT ...